Table 6.
Main outcomes | Reference |
---|---|
Inhibition of uterine contraction | [14, 18, 35, 56, 61–67] |
PG level reduction | [24–27] |
Suppression of COX-2 expression | [25, 35, 36] |
SOD activation and MDA reduction | [36] |
NO, iNOS, and NF-κB reduction | [35, 36, 50] |
Stimulation of somatostatin receptor | [26] |
Intracellular Ca2+ reduction | [18, 35, 56] |
Recovery of phospholipid metabolism | [58] |